Skip to main content
construction release_alert
Profile editing is temporarily unavailable from June 11-24, 2026 while manual profile data entry transitions to Elements. Learn More.
cancel
openRxiv

Genomic MET amplification occurs early in NF1-related malignant peripheral nerve sheath tumor (MPNST) progression and is a potent therapeutic target

Publication ,  Preprint
Peacock, JD; Pridgeon, MG; Tovar, EA; Essenburg, CJ; Bowman, M; Madaj, Z; Koeman, J; Grit, J; Dodd, RD; Cardona, DM; Chen, M; Kirsch, DG ...
October 5, 2017

Duke Scholars

DOI

Publication Date

October 5, 2017
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Peacock, J. D., Pridgeon, M. G., Tovar, E. A., Essenburg, C. J., Bowman, M., Madaj, Z., … Steensma, M. R. (2017). Genomic MET amplification occurs early in NF1-related malignant peripheral nerve sheath tumor (MPNST) progression and is a potent therapeutic target. openRxiv. https://doi.org/10.1101/199000
Peacock, Jacqueline D., Matthew G. Pridgeon, Elizabeth A. Tovar, Curt J. Essenburg, Megan Bowman, Zachary Madaj, Julie Koeman, et al. “Genomic MET amplification occurs early in NF1-related malignant peripheral nerve sheath tumor (MPNST) progression and is a potent therapeutic target.” OpenRxiv, October 5, 2017. https://doi.org/10.1101/199000.
Peacock JD, Pridgeon MG, Tovar EA, Essenburg CJ, Bowman M, Madaj Z, Koeman J, Grit J, Dodd RD, Cardona DM, Chen M, Kirsch DG, Maina F, Dono R, Winn ME, Graveel CR, Steensma MR. Genomic MET amplification occurs early in NF1-related malignant peripheral nerve sheath tumor (MPNST) progression and is a potent therapeutic target. openRxiv. 2017.

DOI

Publication Date

October 5, 2017